CareFusion Flies Solo: Flu Prep, Alaris Relaunch Aid First Earnings Report

CareFusion spun off on its own at a difficult time for a company that depends heavily on hospital capital equipment spending, but with an infusion pump relaunch and a little help from the H1N1 flu, the firm had a relatively successful debut quarter